Thursday, September 15, 2016

BRIEF-Teva launches authorized generic of Cubicin in the U.S.

* Teva strengthens injectables portfolio with the launch of

an authorized generic of Cubicin (Daptomycin for injection) in

the United States

Source text for Eikon:

Further company coverage:

Read more

No comments:

Post a Comment